These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30777653)

  • 21. Association of CHRNA4 gene rs1044396 and rs1044397 polymorphisms with Parkinson's disease symptoms and smoking.
    Zhang LM; Zhang XP; Chen YQ; Ye W
    Genet Mol Res; 2015 May; 14(2):5112-22. PubMed ID: 26125703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between variants in nicotinic acetylcholine receptor genes and smoking cessation in a Chinese rural population.
    Wang Q; Li S; Pan L; Li H; Yang X; Jiang F; Zhang N; Han M; Jia C
    Am J Addict; 2016 Jun; 25(4):297-300. PubMed ID: 27197960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease.
    Lococo F; Cesario A; Petracca-Ciavarella L; Granone P; Russo P
    Curr Med Chem; 2012; 19(34):5863-70. PubMed ID: 23061658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
    Pintarelli G; Galvan A; Pozzi P; Noci S; Pasetti G; Sala F; Pastorino U; Boffi R; Colombo F
    Sci Rep; 2017 Dec; 7(1):16730. PubMed ID: 29196725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variants as risk factors for cigarette smoking at an early age and relapse to smoking cessation treatment: A pilot study.
    Pérez-Rubio G; López-Flores LA; García-Carmona S; García-Gómez L; Noé-Díaz V; Ambrocio-Ortiz E; Nava-Quiroz KJ; Morales-González F; Del Angel-Pablo AD; Ramírez-Venegas A; Sansores RH; Falfán-Valencia R
    Gene; 2019 Apr; 694():93-96. PubMed ID: 30738094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.
    Tanaka K; Miyake Y; Fukushima W; Kiyohara C; Sasaki S; Tsuboi Y; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M; Nakamura Y;
    Neurosci Lett; 2017 Mar; 643():97-102. PubMed ID: 28216333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single nucleotide polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 are associated with heaviness of smoking in women in Northeastern Ontario, Canada.
    Conlon MS; Bewick MA
    Nicotine Tob Res; 2011 Nov; 13(11):1076-83. PubMed ID: 21810735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers.
    Kupiainen H; Kuokkanen M; Kontto J; Virtamo J; Salomaa V; Lindqvist A; Kilpeläinen M; Laitinen T
    COPD; 2016 Aug; 13(4):464-70. PubMed ID: 26751916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of genetic variation in the nicotinic receptor genes on risk for posttraumatic stress disorder.
    Kimbrel NA; Garrett ME; Dennis MF; Liu Y; Patanam I; Workgroup VM; Ashley-Koch AE; Hauser MA; Beckham JC
    Psychiatry Res; 2015 Sep; 229(1-2):326-31. PubMed ID: 26184988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variant within the promoter region of the CHRNA3 gene associated with FTN dependence is not related to self-reported willingness to quit smoking.
    Marques-Vidal P; Kutalik Z; Paccaud F; Bergmann S; Waeber G; Vollenweider P; Cornuz J
    Nicotine Tob Res; 2011 Sep; 13(9):833-9. PubMed ID: 21511889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index.
    Freathy RM; Kazeem GR; Morris RW; Johnson PC; Paternoster L; Ebrahim S; Hattersley AT; Hill A; Hingorani AD; Holst C; Jefferis BJ; Kring SI; Mooser V; Padmanabhan S; Preisig M; Ring SM; Sattar N; Upton MN; Vollenweider P; Waeber G; Sørensen TI; Frayling TM; Watt G; Lawlor DA; Whincup PH; Tozzi F; Davey Smith G; Munafò M
    Int J Epidemiol; 2011 Dec; 40(6):1617-28. PubMed ID: 21593077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pooled analysis of the HLA-DRB1 by smoking interaction in Parkinson disease.
    Chuang YH; Lee PC; Vlaar T; Mulot C; Loriot MA; Hansen J; Lill CM; Ritz B; Elbaz A
    Ann Neurol; 2017 Nov; 82(5):655-664. PubMed ID: 28981958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADHD diagnosis may influence the association between polymorphisms in nicotinic acetylcholine receptor genes and tobacco smoking.
    Polina ER; Rovaris DL; de Azeredo LA; Mota NR; Vitola ES; Silva KL; Guimarães-da-Silva PO; Picon FA; Belmonte-de-Abreu P; Rohde LA; Grevet EH; Bau CH
    Neuromolecular Med; 2014 Jun; 16(2):389-97. PubMed ID: 24375168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SNPs in NRXN1 and CHRNA5 are associated to smoking and regulation of GABAergic and glutamatergic pathways.
    Pérez-Rubio G; Pérez-Rodríguez ME; Fernández-López JC; Ramírez-Venegas A; García-Colunga J; Ávila-Moreno F; Camarena A; Sansores RH; Falfán-Valencia R
    Pharmacogenomics; 2016 Jul; 17(10):1145-1158. PubMed ID: 27355804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of absolute risk of lung cancer mortality in former smokers.
    Halpern MT; Gillespie BW; Warner KE
    J Natl Cancer Inst; 1993 Mar; 85(6):457-64. PubMed ID: 8445673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of current and previous smoking on current phenotype in Parkinson's disease.
    Neshige S; Ohshita T; Neshige R; Maruyama H
    J Neurol Sci; 2021 Aug; 427():117534. PubMed ID: 34130061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association analysis of polymorphisms in VMAT2 and TMEM106B genes for Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy.
    Hu T; Chen Y; Ou R; Wei Q; Cao B; Zhao B; Wu Y; Song W; Chen X; Shang HF
    J Neurol Sci; 2017 Jun; 377():65-71. PubMed ID: 28477711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-nicotinic acetylcholine receptor and tobacco smoke exposure: effects on bronchial hyperresponsiveness in children.
    Torjussen TM; Lødrup Carlsen KC; Munthe-Kaas MC; Mowinckel P; Carlsen KH; Helms PJ; Gerritsen J; Whyte MK; Lenney W; Undlien DE; Shianna KV; Zhu G; Pillai SG
    Pediatr Allergy Immunol; 2012 Feb; 23(1):40-9. PubMed ID: 22017462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smoking Reduces Plasma Bilirubin: Observational and Genetic Analyses in the Copenhagen General Population Study.
    Kodal JB; Çolak Y; Kobylecki CJ; Vedel-Krogh S; Nordestgaard BG; Afzal S
    Nicotine Tob Res; 2020 Jan; 22(1):104-110. PubMed ID: 30202916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-Wide Association Study of Heavy Smoking and Daily/Nondaily Smoking in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Saccone NL; Emery LS; Sofer T; Gogarten SM; Becker DM; Bottinger EP; Chen LS; Culverhouse RC; Duan W; Hancock DB; Hosgood HD; Johnson EO; Loos RJF; Louie T; Papanicolaou G; Perreira KM; Rodriquez EJ; Schurmann C; Stilp AM; Szpiro AA; Talavera GA; Taylor KD; Thrasher JF; Yanek LR; Laurie CC; Pérez-Stable EJ; Bierut LJ; Kaplan RC
    Nicotine Tob Res; 2018 Mar; 20(4):448-457. PubMed ID: 28520984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.